TSHA logo

Taysha Gene Therapies, Inc. (TSHA)

Profile

Full Name

Taysha Gene Therapies, Inc.

Ticker

NASDAQ: TSHA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 24, 2020

Indexes

Not included

Website

https://www.tayshagtx.com

Employees

73

Key Details

Price

$2.93(-0.34%)

Market cap

$799.29M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$8.33M(-46.07% YoY)

Annual EPS

-$0.36(+62.50% YoY)

PE ratio

-

Next earnings date

Nov 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.93
    TSHA price is $2.93

    30-Day Relative Volume

    1.08
    TSHA 30-day relative volume is 1.08

    Price Performance

    Price Most recent change

    -0.34%
    TSHA price was down -0.34% on Aug 18, 2025

    Price YTD change

    +69.36%
    TSHA price is up +69.36% since January 1st

    Price 1-year change

    +30.22%
    TSHA price is up +30.22% year-on-year

    Price 3-year change

    -24.48%
    TSHA price is down -24.48% over the past 3 years

    Price Range

    Price All-time high

    $33.35
    TSHA price is currently -91.21% below its historical high of $33.35

    Price 3-year low

    $0.50
    TSHA price is currently +486.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $799.29M
    TSHA market capitalization is $799.29 million

    Market cap 3-year change

    +401.31%
    TSHA market capitalization is up +401.31% over the past 3 years

    Market cap All-time high

    $1.20B
    TSHA market capitalization is currently -33.33% below its historical high of $1.20 billion

    Market cap sector rank

    71.23%
    TSHA market capitalization is higher than 71.23% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +33.11%
    TSHA shares outstanding is up +33.11% year-on-year

    Shares Outstanding 3-Year Change

    +563.84%
    TSHA shares outstanding is up +563.84% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.19
    TSHA beta is 1.19

    200-day SMA

    $2.09
    TSHA price is currently +40.17% above its 200-day simple moving average

    50-day SMA

    $2.62
    TSHA price is currently +11.86% above its 50-day simple moving average

    RSI

    61.66
    TSHA 14-day relative strength index is 61.66

    Volume

    1.08
    TSHA 30-day relative volume is 1.08

    ATR

    $0.16
    TSHA average true range is $0.16

    10-day Historical Volatility

    43.05%
    TSHA 10-day historical volatility is 43.05%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $8.33M
    TSHA annual revenue is $8.33 million

    Revenue Analysts estimate

    $7.61M
    TSHA annual revenue is currently +9.56% higher than the consensus analysts' forecast

    Revenue 1-year change

    -46.07%
    TSHA annual revenue is down -46.07% year-on-year

    Revenue Sector rank

    46.29%
    TSHA annual revenue is higher than 46.29% of companies in Healthcare sector

    EPS

    EPS

    -$0.36
    TSHA annual earnings per share is -$0.36

    EPS Analysts estimate

    -$0.33
    TSHA annual earnings per share is currently +10.43% higher than the consensus analysts' forecast

    EPS 1-year change

    +62.5%
    TSHA annual earnings per share is up +62.5% year-on-year

    EPS Sector rank

    66.61%
    TSHA annual earnings per share is higher than 66.61% of companies in Healthcare sector

    Profit

    Gross profit

    $7.09M
    TSHA annual gross profit is $7.09 million

    Gross margin

    85.06%
    TSHA annual gross profit margin is 85.06%

    Operating profit

    -$86.62M
    TSHA annual operating income is -$86.62 million

    Operating margin

    -1039.49%
    TSHA annual operating profit margin is -1039.49%

    Net income

    -$89.30M
    TSHA annual net profit is -$89.30 million

    Net margin

    -1071.62%
    TSHA annual net profit margin is -1071.62%

    Expenses

    Total expenses

    $97.63M
    TSHA annual total expenses is $97.63 million

    Operating expenses

    $93.71M
    TSHA annual total operating expenses is $93.71 million

    Cost of goods sold

    $1.25M
    TSHA annual cost of goods sold is $1.25 million

    Selling, general & administrative expenses

    $0.00
    TSHA annual SGA is $0.00

    Depreciation and amortization

    $1.25M
    TSHA annual depreciation & amortization is $1.25 million

    Interest expense

    $0.00
    TSHA annual interest expense is $0.00

    Income tax

    $0.00
    TSHA annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$86.62M
    TSHA annual earnings before interest & taxes is -$86.62 million

    EBITDA

    -$85.38M
    TSHA annual EBITDA is -$85.38 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $276.41M
    TSHA annual total assets is $276.41 million

    Non current assets

    $134.28M
    TSHA annual long term assets is $134.28 million

    Current assets

    $142.13M
    TSHA annual total current assets is $142.13 million

    Cash and cash equivalents

    $139.04M
    TSHA annual cash & cash equivalents is $139.04 million

    Accounts receivable

    -
    TSHA annual accounts receivable value is unknown

    Inventory

    $0.00
    TSHA annual inventory is $0.00

    Liabilities

    Total liabilities

    $204.88M
    TSHA annual total liabilities is $204.88 million

    Long term liabilities

    $178.66M
    TSHA annual total long term liabilities is $178.66 million

    Current liabilities

    $26.23M
    TSHA annual total current liabilities is $26.23 million

    Accounts payable

    $3.59M
    TSHA annual accounts payable is $3.59 million

    Debt

    Total debt

    $63.18M
    TSHA annual total debt is $63.18 million

    Total debt 1-year change

    +3.39%
    TSHA annual total debt is up +3.39% year-on-year

    Long term debt

    $61.30M
    TSHA annual long term debt is $61.30 million

    Short term debt

    $1.88M
    TSHA annual short term debt is $1.88 million

    Equity & Capital

    Shareholders equity

    $71.53M
    TSHA annual stockholders equity is $71.53 million

    Book value

    $71.53M
    TSHA annual book value is $71.53 million

    Retained earnings

    -$602.30M
    TSHA annual retained earnings is -$602.30 million

    Working capital

    $115.77M
    TSHA annual working capital is $115.77 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$81.22M
    TSHA annual cash flow from operations is -$81.22 million

    Cash from operations 1-year change

    -11.24%
    TSHA annual cash flow from operations is down -11.24% year-on-year

    Cash from investing

    -$363.00K
    TSHA annual cash flow from investing activities is -$363.00 thousand

    Cash from investing 1-year change

    +95.06%
    TSHA annual cash flow from investing activities is up +95.06% year-on-year

    Cash from financing

    $76.68M
    TSHA annual cash flow from financing activities is $76.68 million

    Cash from financing 1-year change

    -43.78%
    TSHA annual cash flow from financing activities is down -43.78% year-on-year

    CAPEX

    CAPEX

    $374.00K
    TSHA annual capital expenditures is $374.00 thousand

    CAPEX 1-year change

    -94.92%
    TSHA annual capital expenditures is down -94.92% year-on-year

    Free Cash Flow

    Free cash flow

    -$81.60M
    TSHA annual free cash flow is -$81.60 million

    Free cash flow 1-year change

    -1.51%
    TSHA annual free cash flow is down -1.51% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    85.06%
    TSHA annual gross profit margin is 85.06%

    Operating margin

    -1039.49%
    TSHA annual operating profit margin is -1039.49%

    Net margin

    -1071.62%
    TSHA annual net profit margin is -1071.62%

    ROA & ROE

    ROA

    -32.87%
    TSHA annual return on assets is -32.87%

    ROE

    -121.94%
    TSHA annual return on equity is -121.94%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TSHA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TSHA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.21
    TSHA price to book ratio is 3.21

    PB ratio Sector rank

    68.74%
    TSHA price to book ratio is higher than 68.74% of companies in Healthcare sector

    PS Ratio

    PS ratio

    98.70
    TSHA price to sales ratio is 98.70

    PS ratio Sector rank

    91.18%
    TSHA price to sales ratio is higher than 91.18% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $486.08M
    TSHA enterprise value is $486.08 million

    Enterprise value Sector rank

    67.28%
    TSHA enterprise value is higher than 67.28% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -5.52
    TSHA EV/EBITDA is -5.52

    EV/EBITDA Sector rank

    19.41%
    TSHA EV/EBITDA is higher than 19.41% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.41
    TSHA annual current ratio is 5.41

    Quick ratio

    5.42
    TSHA annual quick ratio is 5.42

    Leverage

    Debt to equity

    0.89
    TSHA annual debt to equity ratio is 0.89

    Interest coverage ratio

    -
    TSHA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    TSHA piotroski f-score value is unknown

    Altman Z-Score

    -1.21
    TSHA altman z-score is -1.21

    Analyst ratings

    Recent major analysts updates

    Aug 13, 25 Wells Fargo
    Overweight
    Aug 13, 25 Canaccord Genuity
    Buy
    Aug 12, 25 Chardan Capital
    Buy
    Jul 11, 25 B of A Securities
    Buy
    Jul 1, 25 Needham
    Buy
    Jun 10, 25 Needham
    Buy
    Jun 3, 25 Canaccord Genuity
    Buy
    Jun 2, 25 Needham
    Buy
    May 29, 25 JMP Securities
    Market Outperform
    May 29, 25 Chardan Capital
    Buy

    Institutional Ownership

    Screeners with TSHA included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Taysha Gene Therapies, Inc.?
    • Does Taysha Gene Therapies, Inc. pay dividends?
    • What sector is Taysha Gene Therapies, Inc. in?
    • What industry is Taysha Gene Therapies, Inc. in?
    • What country is Taysha Gene Therapies, Inc. based in?
    • When did Taysha Gene Therapies, Inc. go public?
    • Is Taysha Gene Therapies, Inc. in the S&P 500?
    • Is Taysha Gene Therapies, Inc. in the NASDAQ 100?
    • Is Taysha Gene Therapies, Inc. in the Dow Jones?
    • When was Taysha Gene Therapies, Inc.'s last earnings report?
    • When does Taysha Gene Therapies, Inc. report earnings?

    What is the ticker symbol for Taysha Gene Therapies, Inc.?

    The ticker symbol for Taysha Gene Therapies, Inc. is NASDAQ:TSHA

    Does Taysha Gene Therapies, Inc. pay dividends?

    No, Taysha Gene Therapies, Inc. does not pay dividends

    What sector is Taysha Gene Therapies, Inc. in?

    Taysha Gene Therapies, Inc. is in the Healthcare sector

    What industry is Taysha Gene Therapies, Inc. in?

    Taysha Gene Therapies, Inc. is in the Biotechnology industry

    What country is Taysha Gene Therapies, Inc. based in?

    Taysha Gene Therapies, Inc. is headquartered in United States

    When did Taysha Gene Therapies, Inc. go public?

    Taysha Gene Therapies, Inc.'s initial public offering (IPO) was on September 24, 2020

    Is Taysha Gene Therapies, Inc. in the S&P 500?

    No, Taysha Gene Therapies, Inc. is not included in the S&P 500 index

    Is Taysha Gene Therapies, Inc. in the NASDAQ 100?

    No, Taysha Gene Therapies, Inc. is not included in the NASDAQ 100 index

    Is Taysha Gene Therapies, Inc. in the Dow Jones?

    No, Taysha Gene Therapies, Inc. is not included in the Dow Jones index

    When was Taysha Gene Therapies, Inc.'s last earnings report?

    Taysha Gene Therapies, Inc.'s most recent earnings report was on August 12, 2025

    When does Taysha Gene Therapies, Inc. report earnings?

    The next expected earnings date for Taysha Gene Therapies, Inc. is November 13, 2025
    On this page